Service de Microbiologie, Hôpital Beaujon, AP-HP, F-92110, Clichy, France.
INSERM and University Paris Diderot, IAME, UMR 1137, 16 rue Henri Huchard, F-75018, Paris, France.
Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):383-393. doi: 10.1007/s10096-018-3438-9. Epub 2018 Nov 28.
This study aimed to assess characteristics associated with infections due to carbapenem-resistant Enterobacteriaceae (CRE), producing (CPE) or not producing (non-CPE) carbapenemase, among hospitalised patients in 2014-2016 in France. Case-patients with CRE were compared to two control populations. In multivariate analysis comparing 160 CRE cases to 160 controls C1 (patients with a clinical sample positive for carbapenem-susceptible Enterobacteriaceae), five characteristics were linked to CRE: male gender (OR = 1.9; 95% CI = 1.3-3.4), travel in Asia (OR = 10.0; 95% CI = 1.1-91.2) and hospitalisation in (OR = 2.4; 95% CI = 1.3-4.4) or out of (OR = 4.4; 95% CI = 0.8-24.1) France in the preceding 12 months, infection in the preceding 3 months (OR = 3.0; 95% CI = 1.5-5.9), and antibiotic receipt between admission and inclusion (OR = 1.9; 95% CI = 1.0-3.3). In multivariate analysis comparing 148 CRE cases to 148 controls C2 [patients with culture-negative sample(s)], four characteristics were identified: prior infection (OR = 3.3; 95% CI = 1.6-6.8), urine drainage (OR = 3.0; 95% CI = 1.5-6.1) and mechanical ventilation (OR = 3.7; 95% CI = 1.1-13.0) during the current hospitalisation, and antibiotic receipt between admission and inclusion (OR = 6.6; 95% CI = 2.8-15.5). Univariate analyses comparing separately CPE cases to controls (39 CPE vs C1 and 36 CPE vs C2) and non-CPE cases to controls (121 non-CPE vs C1 and 112 non-CPE vs C2), concomitantly with comparison of CPE to non-CPE cases showed that only CPE cases were at risk of previous travel and hospitalisation abroad. This study shows that, among CRE, risk factors are different for CPE and non-CPE infection, and suggests that question patients about their medical history and lifestyle should help for early identification of patients at risk of CPE among patients with CRE.
本研究旨在评估 2014-2016 年法国住院患者中碳青霉烯类耐药肠杆菌科(CRE)感染(产或不产碳青霉烯酶)的相关特征。将 CRE 病例与两组对照人群进行比较。在将 160 例 CRE 病例与 160 例对照(C1,临床样本中碳青霉烯类敏感肠杆菌科阳性)进行多变量分析时,有五个特征与 CRE 相关:男性(OR=1.9;95%CI=1.3-3.4)、亚洲旅行(OR=10.0;95%CI=1.1-91.2)和住院(OR=2.4;95%CI=1.3-4.4)或出国(OR=4.4;95%CI=0.8-24.1),住院前 12 个月内感染(OR=3.0;95%CI=1.5-5.9),以及住院期间至纳入前接受抗生素治疗(OR=1.9;95%CI=1.0-3.3)。在将 148 例 CRE 病例与 148 例对照(C2,培养阴性样本)进行多变量分析时,有四个特征与 CRE 相关:先前感染(OR=3.3;95%CI=1.6-6.8)、尿液引流(OR=3.0;95%CI=1.5-6.1)和当前住院期间机械通气(OR=3.7;95%CI=1.1-13.0),以及住院期间至纳入前接受抗生素治疗(OR=6.6;95%CI=2.8-15.5)。将 CPE 病例与对照(39 例 CPE 与 C1,36 例 CPE 与 C2)和非 CPE 病例与对照(121 例非 CPE 与 C1,112 例非 CPE 与 C2)分别进行单变量分析,并同时将 CPE 病例与非 CPE 病例进行比较,结果显示只有 CPE 病例有出国旅行和住院的风险。本研究表明,在 CRE 中,CPE 和非 CPE 感染的危险因素不同,提示应询问患者的病史和生活方式,以帮助早期识别 CRE 患者中 CPE 感染的高危患者。